Increased sugar intake as a form of compensatory hyperphagia in patients with type 2 diabetes under dapagliflozin treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Increased sugar intake as a form of compensatory hyperphagia in patients with type 2 diabetes under dapagliflozin treatment

Published:2018-01 Issue: Volume:135 Page:178-184
ISSN:0168-8227
Container-title:Diabetes Research and Clinical Practice
language:en
Short-container-title:Diabetes Research and Clinical Practice

Author:

Horie Ichiro,Abiru Norio,Hongo Ryoko,Nakamura Takeshi,Ito Ayako,Haraguchi Ai,Natsuda Shoko,Sagara Ikuko,Ando Takao,Kawakami Atsushi

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference30 articles.

1. Glucose transporters in human renal proximal tubular cells isolated from the urine of patients with non-insulin-dependent diabetes;Rahmoune;Diabetes,2005

2. SGLT2 inhibition – a novel strategy for diabetes treatment;Chao;Nat Rev Drug Discovery,2010

3. Energy balance after sodium-glucose cotransporter 2 inhibition;Ferrannini;Diabetes Care,2015

4. How strongly does appetite counter weight loss? Quantification of the feedback control of human energy intake;Polidori;Obesity (Silver Spring),2016

5. Weight loss induced by chronic dapagliflozin treatment is attenuated by compensatory hyperphagia in diet-induced obese (DIO) rats;Devenny;Obesity (Silver Spring),2012

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Changes in daily intake of nutrients and foods including confectionery after the initiation of empagliflozin in Japanese patients with type 2 diabetes: a pilot study;BMC Nutrition;2024-07-04

2. Obesity and the kidney: mechanistic links and therapeutic advances;Nature Reviews Endocrinology;2024-02-13

3. Sodium-glucose co-transporter 2 inhibitors and Sarcopenia: A controversy that must be solved;Clinical Nutrition;2023-12

4. Alleviating effects and mechanisms of action of large-leaf yellow tea drinking on diabetes and diabetic nephropathy in mice;Food Science and Human Wellness;2023-09

5. Diabetes-Alzheimer's connection in older age: SGLT2 inhibitors as promising modulators of disease pathways;Ageing Research Reviews;2023-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3